BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,448,000 | -52.6% | 12,216 | -44.4% | 0.27% | -47.6% |
| Q3 2021 | $3,054,000 | +30.8% | 21,989 | -8.6% | 0.52% | +42.7% |
| Q2 2021 | $2,335,000 | +368.9% | 24,048 | +230.1% | 0.36% | +381.3% |
| Q1 2021 | $498,000 | -62.4% | 7,286 | -52.8% | 0.08% | -65.4% |
| Q4 2020 | $1,324,000 | +29.3% | 15,447 | -1.9% | 0.22% | -10.7% |
| Q3 2020 | $1,024,000 | -52.3% | 15,752 | -46.4% | 0.24% | -48.8% |
| Q2 2020 | $2,148,000 | -17.4% | 29,385 | -50.5% | 0.48% | -25.3% |
| Q2 2019 | $2,600,000 | -18.3% | 59,383 | -4.0% | 0.64% | -18.6% |
| Q1 2019 | $3,183,000 | – | 61,836 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |